title: Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
authors.affiliation: Department of Opthalmology, University Hospitals Leuven, Leuven, Belgium.
authors.forename: Evelien
authors.initials: E
authors.lastname: Dewilde
authors.forename: Lien
authors.initials: L
authors.lastname: Delaere
authors.forename: Isaline
authors.initials: I
authors.lastname: Vaninbroukx
authors.forename: Joachim
authors.initials: J
authors.lastname: Van Calster
authors.forename: Peter
authors.initials: P
authors.lastname: Stalmans
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007431:Intraoperative Complications; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012166:Retinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
chemical_list: D020533:Angiogenesis Inhibitors; D005343:Fibrinolytic Agents; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D010959:Tissue Plasminogen Activator